9月 2023, <>
英文版
加利福尼亚州红木城,09年2023月31日(环球通讯社)--Soleno Therapeutics,Inc.(Soleno)(纳斯达克股票代码:SLNO)...查看全文
$Soleno Therapeutics(SLNO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-053695 Size: 5 KB 网页链接
$Soleno Therapeutics(SLNO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-22-256241 Act: 34 Size: 175 KB 网页链接
$Soleno Therapeutics(SLNO)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001193125-22-228929 Act: 34 Size: 159 KB 网页链接
$Soleno Therapeutics(SLNO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-22-028387 Size: 28 KB 网页链接
$Soleno Therapeutics(SLNO)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-22-218656 Act: 34 Size: 229 KB 网页链接
$Soleno Therapeutics(SLNO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-22-028965 Act: 34 Size: 6 MB 网页链接
$Soleno Therapeutics(SLNO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-22-217340 Act: 34 Size: 233 KB 网页链接
$Soleno Therapeutics(SLNO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-043426 Size: 5 KB 网页链接
$Soleno Therapeutics(SLNO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-043427 Size: 5 KB 网页链接
$Soleno Therapeutics(SLNO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-043428 Size: 5 KB 网页链接